Clinical trials
Active, not recruiting Non-alcoholic Fatty Liver Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gannex Pharma Co., Ltd. | 1 |
| Guangdong Raynovent Biotech Co., Ltd | 1 |
| Inventiva Pharma | 1 |
| National Research Institute for Family Planning, China | 1 |
| Novo Nordisk A/S | 1 |
| Shanghai East Hospital | 1 |
| Singlera Genomics Inc. | 1 |
| The University of Hong Kong | 1 |
| Visirna Therapeutics HK Limited | 1 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 12 |
| Carcinoma, Hepatocellular | 1 |
| Congenital Abnormalities | 1 |
| Fibrosis | 1 |
| Hepatitis B | 1 |
| Hepatitis C | 1 |
| Liver Cirrhosis | 1 |
| Liver Diseases | 1 |
| Obesity | 1 |
| Overweight | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.